How do women trade-off benefits and risks in chemotherapy treatment decisions based on gene expression profiling for early-stage breast cancer? A discrete choice experiment

OBJECTIVES: Gene expression profiling (GEP) of tumours informs baseline risk prediction, potentially affecting adjuvant chemotherapy decisions for women with early-stage breast cancer. Since only 15% will experience a recurrence, concerns have been raised about potential harms from overtreatment and...

Descripción completa

Detalles Bibliográficos
Autores principales: Marshall, Deborah A, Deal, Ken, Bombard, Yvonne, Leighl, Natasha, MacDonald, Karen V, Trudeau, Maureen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2016
Materias:
Health Services Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4893875/
https://www.ncbi.nlm.nih.gov/pubmed/27256091
http://dx.doi.org/10.1136/bmjopen-2015-010981

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4893875/
https://www.ncbi.nlm.nih.gov/pubmed/27256091
http://dx.doi.org/10.1136/bmjopen-2015-010981

Ejemplares similares